The aryl hydrocarbon receptor governs epithelial cell invasion during oropharyngeal candidiasis

mBio

Volumn 8, Issue 2, 2017, Pages

  Solis, Norma V ^a   Swidergall, Marc ^a   Bruno, Vincent M ^b   Gaffen, Sarah L ^c   Filler, Scott G ^a,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aryl hydrocarbon receptor; Candida albicans; Epithelial cells; Host cell invasion; Interferon gamma

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CH 223191; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GEFITINIB; KYNURENINE; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; AHR PROTEIN, MOUSE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; EGFR PROTEIN, MOUSE;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDIASIS; CELL INVASION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUTH EPITHELIUM; MOUTH MUCOSA; NONHUMAN; NORMAL HUMAN; OROPHARYNX CANDIDIASIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; THRUSH;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CANDIDIASIS, ORAL; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; EPITHELIAL CELLS; MICE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 85019154017     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00025-17     Document Type: Article

References (60)

1. Phelan JA, Saltzman BR, Friedland GH, Klein RS. 1987. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 64:50-56. https://doi.org/10.1016/0030-4220(87)90116-2.
2. Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W, Jr, Lang W, Samuel M, Buchbinder SP, Hessol NA, Lifson AR. 1991. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5:519-525. https:// doi.org/10.1097/00002030-199105000-00007.
3. Armstrong-James D, Meintjes G, Brown GD. 2014. A neglected epidemic: fungal infections in HIV/AIDS. Trends Microbiol 22:120-127. https://doi.org/10.1016/j.tim.2014.01.001.
4. Kerdpon D, Pongsiriwet S, Pangsomboon K, Iamaroon A, Kampoo K, Sretrirutchai S, Geater A, Robison V. 2004. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 10:138-144. https://doi.org/10.1046/j.1601-0825.2003.00990.x.
5. Chidzonga MM. 2003. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 9:317-322. https://doi.org/10.1034/j.1601-0825.2003.00962.x.
6. Castro LA, Alvarez MI, Martinez E. 2013. Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia. Mycopathologia 175:91-98. https://doi.org/10.1007/s11046-012-9593-0.
7. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA. 1994. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 97:339-346. https://doi.org/10.1016/0002-9343(94)90300-X.
8. Revankar SG, Dib OP, Kirkpatrick WR, Mc Atee RK, Fothergill AW, Rinaldi MG, Redding SW, Patterson TF. 1998. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients. Clin Infect Dis 26: 960-963. https://doi.org/10.1086/513950.
9. Redding SW, Zellars RC, Kirkpatrick WR, Mc Atee RK, Caceres MA, Fothergill AW, Lopez-Ribot JL, Bailey CW, Rinaldi MG, Patterson TF. 1999. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37:3896-3900.
10. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. 1997. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren’s syndrome. J Otolaryngol 26:300-305.
11. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. 1999. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 16:675-679.
12. Swidergall M, Filler SG. 2017. Oropharyngeal candidiasis: fungal invasion and epithelial cell responses. PLo S Pathog 13:e1006056. https://doi.org/ 10.1371/journal.ppat.1006056.
13. Montes LF, Wilborn WH. 1968. Ultrastructural features of host-parasite relationship in oral candidiasis. J Bacteriol 96:1349-1356.
14. Cawson RA, Rajasingham KC. 1972. Ultrastructural features of the invasive phase of Candida albicans. Br J Dermatol 87:435-443. https://doi.org/10.1111/j.1365-2133.1972.tb01591.x.
15. Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, E Edwards JE, Jr, Filler SG. 2005. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7:499-510. https://doi.org/10.1111/j.1462-5822.2004.00476.x.
16. Wachtler B, Citiulo F, Jablonowski N, Forster S, Dalle F, Schaller M, Wilson D, Hube B. 2012. Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process. PLo S One 7:e36952. https://doi.org/10.1371/journal.pone.0036952.
17. Dalle F, Wachtler B, L’Ollivier C, Holland G, Bannert N, Wilson D, Labruere C, Bonnin A, Hube B. 2010. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 12:248-271. https://doi.org/10.1111/j.1462-5822.2009.01394.x.
18. Zhu W, Filler SG. 2010. Interactions of Candida albicans with epithelial cells. Cell Microbiol 12:273-282. https://doi.org/10.1111/j.1462-5822.2009.01412.x.
19. Zakikhany K, Naglik JR, Schmidt-Westhausen A, Holland G, Schaller M, Hube B. 2007. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell Microbiol 9:2938-2954. https://doi.org/10.1111/j.1462-5822.2007.01009.x.
20. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE, Filler SG. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLo S Biol 5:e64. https://doi.org/10.1371/journal.pbio.0050064.
21. Zhu W, Phan QT, Boontheung P, Solis NV, Loo JA, Filler SG. 2012. EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc Natl Acad Sci U S A 109:14194-14199. https://doi.org/10.1073/pnas.1117676109.
22. Sun JN, Solis NV, Phan QT, Bajwa JS, Kashleva H, Thompson A, Liu Y, Dongari-Bagtzoglou A, Edgerton M, Filler SG. 2010. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLo S Pathog 6:e1001181. https://doi.org/10.1371/journal.ppat.1001181.
23. Delsing CE, Gresnigt MS, Leentjens J, Preijers F, Frager FA, Kox M, Monneret G, Venet F, Bleeker-Rovers CP, van de Veerdonk FL, Pickkers P, Pachot A, Kullberg BJ, Netea MG. 2014. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis 14:166. https://doi.org/10.1186/1471-2334-14-166.
24. Bodasing N, Seaton RA, Shankland GS, Pithie A. 2002. Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient. J Antimicrob Chemother 50:765-766. https://doi.org/10.1093/ jac/dkf206.
25. Riddell LA, Pinching AJ, Hill S, Ng TT, Arbe E, Lapham GP, Ash S, Hillman R, Tchamouroff S, Denning DW, Parkin JM. 2001. A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. AIDS Res Hum Retroviruses 17:789-797. https://doi.org/10.1089/088922201750251981.
26. Gozalbo D, Maneu V, Gil ML. 2014. Role of IFN-gamma in immune responses to Candida albicans infections. Front Biosci 19:1279-1290. https://doi.org/10.2741/4281.
27. Fratti RA, Ghannoum MA, Edwards JE, Jr., Filler SG. 1996. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun 64:4714-4718.
28. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG. 2000. Human keratinocytes that express h TERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20:1436-1447. https://doi.org/10.1128/MCB.20.4.1436-1447.2000.
29. Phan QT, Eng DK, Mostowy S, Park H, Cossart P, Filler SG. 2013. Role of endothelial cell septin 7 in the endocytosis of Candida albicans. m Bio 4:e00542-13. https://doi.org/10.1128/m Bio.00542-13.
30. Zhang Z, Han Y, Song J, Luo R, Jin X, Mu D, Su S, Ji X, Ren YF, Liu H. 2015. Interferon-_ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity. J Oral Pathol Med 44:15-27. https://doi.org/10.1111/jop.12224.
31. Mellor AL, Munn DH. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774. https://doi.org/10.1038/nri1457.
32. Chen Y, Guillemin GJ. 2009. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:1-19.
33. Mezrich JD, Fechner JH, Zhang X, Johnson BP, BurlinghamWJ,BradfieldCA.2010.AninteractionbetweenkynurenineandthearylhydrocarbonreceptorcangenerateregulatoryTcells.JImmunol185:3190-3198.https://doi.org/10.4049/jimmunol.0903670.
34. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M. 2011. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:197-203. https://doi.org/10.1038/ nature10491.
35. Enan E, Matsumura F. 1996. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 52:1599-1612. https://doi.org/10.1016/S0006-2952(96)00566-7.
36. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. 1999. c-Srcmediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274:8335-8343. https://doi.org/10.1074/jbc.274.12.8335.
37. Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, Saurat JH, Roosnek E, Chizzolini C. 2010. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 40:2450-2459. https://doi.org/10.1002/eji.201040461.
38. Yamaoka T, Frey MR, Dise RS, Bernard JK, Polk DB. 2011. Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution. Am J Physiol Gastrointest Liver Physiol 301:G368-G376. https://doi.org/10.1152/ajpgi.00327.2010.
39. Villar CC, Kashleva H, Dongari-Bagtzoglou A. 2004. Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol Immunol 19:262-269. https://doi.org/10.1111/j.1399-302X.2004.00150.x.
40. Wagage S, John B, Krock BL, Hall AO, Randall LM, Karp CL, Simon MC, Hunter CA. 2014. The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J Immunol 192:1661-1670. https://doi.org/10.4049/ jimmunol.1300497.
41. Kimura A, Abe H, Tsuruta S, Chiba S, Fujii-Kuriyama Y, Sekiya T, Morita R, Yoshimura A. 2014. Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production. Int Immunol 26:209-220. https://doi.org/10.1093/ intimm/dxt067.
42. Huai W, Zhao R, Song H, Zhao J, Zhang L, Zhang L, Gao C, Han L, Zhao W. 2014. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nat Commun 5:4738. https://doi.org/10.1038/ncomms5738.
43. Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, Du Hadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P. 2014. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511:184-190. https://doi.org/10.1038/ nature13323.
44. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D’Angelo C, Massi-Benedetti C, Fallarino F, Carvalho A, Puccetti P, Romani L. 2013. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372-385. https://doi.org/10.1016/j.immuni.2013.08.003.
45. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311. https:// doi.org/10.1084/jem.20081463.
46. Burova E, Vassilenko K, Dorosh V, Gonchar I, Nikolsky N. 2007. Interferon gamma-dependent transactivation of epidermal growth factor receptor. FEBS Lett 581:1475-1480. https://doi.org/10.1016/j.febslet.2007.03.002.
47. Paul G, Marchelletta RR, Mc Cole DF, Barrett KE. 2012. Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport. J Biol Chem 287:2144-2155. https://doi.org/10.1074/jbc.M111.318139.
48. Huang F, Sorkin A. 2005. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Mol Biol Cell 16:1268-1281. https://doi.org/10.1091/mbc.E04-09-0832.
49. Jiang X, Huang F, Marusyk A, Sorkin A. 2003. Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell 14: 858-870. https://doi.org/10.1091/mbc.E02-08-0532.
50. Moreno-Ruiz E, Galan-Diez M, Zhu W, Fernandez-Ruiz E, d’Enfert C, Filler SG, Cossart P, Veiga E. 2009. Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell Microbiol 11:1179-1189. https://doi.org/10.1111/j.1462-5822.2009.01319.x.
51. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS. 2006. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366:2-16. https://doi.org/10.1016/j.gene.2005.10.018.
52. Irby RB, Yeatman TJ. 2000. Role of Src expression and activation in human cancer. Oncogene 19:5636-5642. https://doi.org/10.1038/sj.onc.1203912.
53. Conti HR, Bruno VM, Childs EE, Daugherty S, Hunter JP, Mengesha BG, Saevig DL, Hendricks MR, Coleman BM, Brane L, Solis N, Cruz JA, Verma AH, Garg AV, Hise AG, Richardson JP, Naglik JR, Filler SG, Kolls JK, Sinha S, Gaffen SL. 2016. IL-17 receptor signaling in oral epithelial cells is critical for protection against oropharyngeal candidiasis. Cell Host Microbe 20:606-617. https://doi.org/10.1016/j.chom.2016.10.001.
54. Kamai Y, Kubota M, Kamai Y, Hosokawa T, Fukuoka T, Filler SG. 2001. New model of oropharyngeal candidiasis in mice. Antimicrob Agents Chemother 45:3195-3197. https://doi.org/10.1128/AAC.45.11.3195-3197.2001.
55. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
56. Cunningham F, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Giron CG, Gordon L, HourlierT,HuntSE,JanacekSH,JohnsonN,JuettemannT,KahariAK,KeenanS,MartinFJ,MaurelT,McLarenW,MurphyDN,NagR,OverduinB,ParkerA,PatricioM,PerryE,PignatelliM,RiatHS,SheppardD,TaylorK,ThormannA,VulloA,WilderSP,ZadissaA,AkenBL,BirneyE,HarrowJ,KinsellaR,MuffatoM,RuffierM,SearleSM,SpudichG,TrevanionSJ,YatesA,ZerbinoDR,FlicekP.2015.Ensembl2015.NucleicAcidsRes43:D662-D669.https://doi.org/10.1093/nar/gku1010.
57. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14:R36. https://doi.org/10.1186/gb-2013-14-4-r36.
58. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11:R106. https://doi.org/10.1186/gb-2010-11-10-r106.
59. Solis NV, Filler SG. 2012. Mouse model of oropharyngeal candidiasis. Nat Protoc 7:637-642. https://doi.org/10.1038/nprot.2012.011.
60. Luo G, Ibrahim AS, Spellberg B, Nobile CJ, Mitchell AP, Fu Y. 2010. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis 201:1718-1728. https://doi.org/10.1086/652407.